The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK : new insights in ALK-mediated pathogenesis and the treatment of ALCLBOCCALATTE, Francesco E; VOENA, Claudia; LEE, Kimberly et al.Blood. 2009, Vol 113, Num 12, pp 2776-2790, issn 0006-4971, 15 p.Article

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaCORRADINI, Paolo; CAVO, Michele; RUSSELL, Nigel et al.Blood. 2003, Vol 102, Num 5, pp 1927-1929, issn 0006-4971, 3 p.Article

The tyrosine phosphatase shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migrationVOENA, Claudia; CONTE, Chiara; AMBROGIO, Chiara et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4278-4286, issn 0008-5472, 9 p.Article

Pcr-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyLADETTO, Marco; DRANDI, Daniela; FALCO, Patrizia et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1398-1403, issn 0732-183X, 6 p.Article

Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34⁺ cells with small- and large-scale Miltenyi cell sorting systemVOENA, Claudia; LOCATELLI, Giovanni; LUSSO, Paolo et al.British journal of haematology. 2002, Vol 117, Num 3, pp 642-645, issn 0007-1048Article

NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma CellsAMBROGIO, Chiara; MARTINENGO, Cinzia; VOENA, Claudia et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 22, pp 8611-8619, issn 0008-5472, 9 p.Article

p130Cas mediates the transforming properties of the anaplastic lymphoma kinaseAMBROGIO, Chiara; VOENA, Claudia; BOERI ERBA, Elisabetta et al.Blood. 2005, Vol 106, Num 12, pp 3907-3916, issn 0006-4971, 10 p.Article

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancerBREGNI, Marco; DODERO, Anna; PECCATORI, Jacopo et al.Blood. 2002, Vol 99, Num 11, pp 4234-4236, issn 0006-4971Article

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesCORRADINI, Paolo; TARELLA, Corrado; CICERI, Fabio et al.Blood. 2002, Vol 99, Num 1, pp 75-82, issn 0006-4971Article